Evidence map›Paper›PMID 33821553›Full record

ArticleJournal of the International AIDS Society2021

The impact of disruptions due to COVID-19 on HIV transmission and control among men who have sex with men in China.

Ross D Booton, Gengfeng Fu, Louis MacGregor, Jianjun Li, Jason J Ong, Joseph D Tucker, Katherine Me Turner, Weiming Tang, Peter Vickerman, Kate M Mitchell

Open access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 49 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 4 countries.

Ross D BootonUniversity of Bristol, Bristol, United Kingdom.ORCID 0000-0002-3013-4179
Gengfeng FuJiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Louis MacGregorUniversity of Bristol, Bristol, United Kingdom.
Jianjun LiJiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Jason J OngSocial Entrepreneurship to Spur Health (SESH) Global, Guangzhou, China.ORCID 0000-0001-5784-7403
Joseph D TuckerSocial Entrepreneurship to Spur Health (SESH) Global, Guangzhou, China.ORCID 0000-0003-2804-1181
Katherine Me TurnerUniversity of Bristol, Bristol, United Kingdom.
Weiming TangSocial Entrepreneurship to Spur Health (SESH) Global, Guangzhou, China.
Peter VickermanUniversity of Bristol, Bristol, United Kingdom.ORCID 0000-0002-8291-5890
Kate M MitchellMRC Centre for Global Infectious Disease Analysis, Imperial College London, London, United Kingdom.ORCID 0000-0002-7050-4787
University of Bristol · GBUniversity of North Carolina at Chapel Hill · USHealth First · USImperial College London · GBJiangsu Provincial Center for Disease Control and Prevention · CNLondon School of Hygiene & Tropical Medicine · GB

Funding

Spurring Innovation in HIV Testing and Linkage: A Crowdsourcing Approach -Diversity SupplementR01AI114310 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TUCKER, JOSEPH DAVID, WEI, CHONGYI · 2014 to 2018
$3.3M
Mentoring Multidisciplinary Global HIV Patient-Oriented ResearchK24AI143471 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph David Tucker · 2019 to 2026
$1.4M
Elizabeth Blackwell Institute ISSF3: 204813/Z/16/ZHealth Data Research UK CFC0129Medical Research Council MC_PC_19012Medical Research Council MR/R015600/1MRC Centre for Global Infectious Disease Analysis MR/R015600/1National Institute of Allergy and Infectious Diseases 1R01AI114310National Institute of Allergy and Infectious Diseases NIAID K24AI143471NIAID NIH HHS K24 AI143471NIAID NIH HHS R01 AI114310NIHR Health Protection Research Unit in Behavioural Science and Evaluation at the University of Bristol NIHR200877Wellcome Trust
6 · The paper itself

Abstract

introductionThe COVID-19 pandemic is impacting HIV care globally, with gaps in HIV treatment expected to increase HIV transmission and HIV-related mortality. We estimated how COVID-19-related disruptions could impact HIV transmission and mortality among men who have sex with men (MSM) in four cities in China, over a one- and five-year time horizon.

methodsRegional data from China indicated that the number of MSM undergoing facility-based HIV testing reduced by 59% during the COVID-19 pandemic, alongside reductions in ART initiation (34%), numbers of all sexual partners (62%) and consistency of condom use (25%), but initial data indicated no change in viral suppression. A mathematical model of HIV transmission/treatment among MSM was used to estimate the impact of disruptions on HIV infections/HIV-related deaths. Disruption scenarios were assessed for their individual and combined impact over one and five years for 3/4/6-month disruption periods, starting from 1 January 2020.

resultsOur model predicted new HIV infections and HIV-related deaths would be increased most by disruptions to viral suppression, with 25% reductions (25% virally suppressed MSM stop taking ART) for a three-month period increasing HIV infections by 5% to 14% over one year and deaths by 7% to 12%. Observed reductions in condom use increased HIV infections by 5% to 14% but had minimal impact (<1%) on deaths. Smaller impacts on infections and deaths (<3%) were seen for disruptions to facility HIV testing and ART initiation, but reduced partner numbers resulted in 11% to 23% fewer infections and 0.4% to 1.0% fewer deaths. Longer disruption periods (4/6 months) amplified the impact of disruption scenarios. When realistic disruptions were modelled simultaneously, an overall decrease in new HIV infections occurred over one year (3% to 17%), but not for five years (1% increase to 4% decrease), whereas deaths mostly increased over one year (1% to 2%) and five years (1.2 increase to 0.3 decrease).

conclusionsThe overall impact of COVID-19 on new HIV infections and HIV-related deaths is dependent on the nature, scale and length of the various disruptions. Resources should be directed to ensuring levels of viral suppression and condom use are maintained to mitigate any adverse effects of COVID-19-related disruption on HIV transmission and control among MSM in China.

Indexed as

Homosexuality, MaleSARS-CoV-2ChinaCOVID-19HIV InfectionsHumansMaleSafe SexCOVID-19 pandemicHIV transmissionkey and vulnerable populationsmen who have sex with menmodellingPeople’s Republic of China

Identifiers

PMID33821553
PMCPMC8022092
OpenAlexW3147387785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.